CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c‐Met signaling pathway

C‐X‐C chemokine receptor type 4 (CXCR4) expression is associated with poor prognosis of hepatocellular carcinoma (HCC). The aim of this study was to explore the biological role of CXCR4 in gefitinib resistance of HCC. Compared with a normal, non‐gefitinib‐resistant, human HCC cell line (Huh7), CXCR4...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dali, Yang, Zhiqiang, Chen, Chen, Zhang, Zhipeng, Yu, Yangsheng, Li, Zhituo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564344/
https://www.ncbi.nlm.nih.gov/pubmed/34555268
http://dx.doi.org/10.1002/2211-5463.13305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564344/
https://www.ncbi.nlm.nih.gov/pubmed/34555268
http://dx.doi.org/10.1002/2211-5463.13305

Ejemplares similares